Dr. Chalas is Chief of Gynecologic Oncology and Director of Clinical Cancer Services at Winthrop-University Hospital in Mineola, New York.
Dr. Chalas reports that she receives grant or research support from NCI and is a speaker for Astra-Zeneca.
An interview with Eva Chalas, MD
As gynecologists are well aware, in November 2014, the FDA issued a safety communication, warning “against the use of laparoscopic power morcellators in the majority of women undergoing myomectomy or hysterectomy for treatment of fibroids.” Now, a group of 46 experts in gynecologic surgery, including Dr. Eva Chalas, question the FDA’s decision and provide their own clinical recommendations for FDA consideration.
In this interview with Dr. Chalas, she discusses:
why this letter needed to be written now
why, as an oncologist, she felt she needed to sign the letter
concerns with the data the FDA used to make their recommendation 1 year ago